July 24, 2018
Fresh discussions will be necessary for so-called “biosame” products, which are manufactured under the exact same conditions as those for their originators, Tomonori Nakayama, pharmaceutical management director of the health ministry, told Jiho. Authorized biosimilars (ABs), have two types -...read more